Proteomics in translational cancer research: toward an integrated approach.
about
Current application of proteomics in biomarker discovery for inflammatory bowel diseaseReverse phase protein microarrays advance to use in clinical trialsMALDI imaging mass spectrometry--painting molecular picturesMass spectrometric analysis of protein mixtures at low levels using cleavable 13C-isotope-coded affinity tag and multidimensional chromatography.Immunoexpression analysis and prognostic value of BLCAP in breast cancerUse of proteomic analysis to monitor responses to biological therapies.Proteomics in cancer vaccine development.SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique.Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis.Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.Clinical proteomics of breast cancerHigh throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platformImpact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinomaProteomic technology for biomarker profiling in cancer: an updateClinical proteomics: present and future prospects.Breast cancer: when proteomics challenges biological complexity.Proteomic analysis of Class IV lupus nephritis.Impact of proteomics on bladder cancer research.Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo.Individualised cancer therapeutics: dream or reality?Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice.Enrichment and proteomic analysis of plasma membrane from rat dorsal root ganglions.Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells.Integrative oncoproteomics strategies for anticancer drug discovery.Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics.Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway.A single lysis solution for the analysis of tissue samples by different proteomic technologies.Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer.Indications for cell stress in response to adenoviral and baculoviral gene transfer observed by proteome profiling of human cancer cells.Global analysis of the cortical neuron proteome.Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.
P2860
Q28078755-D7B5263F-96D9-4630-8594-4B3B79E0ABD9Q28384553-605C6720-135E-432A-B379-1FDBBF15FD5EQ30472639-08B10C4F-F8F9-4811-B35D-327326120B0BQ30937226-65E1D843-B49D-4712-A773-8856426E8E73Q31103058-E334B6E1-A774-4BE4-9B20-FB4AE3677558Q33196034-588E1978-2A9B-4B64-A535-956E6F91A459Q33215044-D0D97F5C-EC42-412B-B11A-7AC087A11CA9Q33222839-EB24323E-D090-4F39-885C-C9EFC1B31705Q33224181-6C5AE914-6D39-4CF0-AE18-9344622C0F00Q33231796-D8593236-8307-4026-8C47-A6E53DEEA3BCQ33237312-2BBE6134-E8DB-46BC-9266-33BB2BA39B96Q33450135-FE4A9925-2C2D-480B-9D13-C5AA276360D8Q33520512-1D5E3EF0-0D0E-4286-AA1D-7A65E7471E27Q33597980-B666A119-D2DA-4170-AD63-5B6585205799Q33885885-0FE71F40-CEF1-4682-88AD-F6C15F2B202BQ34074494-8EC42D15-240F-428A-BF1F-CA68397DBB3CQ34420593-C37C92EB-3C45-44C8-86A0-D48552F6D1A3Q34657835-26C79347-7B96-42C3-9A56-B5044DED0305Q35053674-EC54DF84-6514-4629-B2AD-DF5D841AA740Q35140561-71F9A861-99FD-4FC6-A63E-04A14CDDA24BQ35184512-14485DEF-CAF4-4CE5-83F3-C178FCE9587DQ35785226-4CDAE5E9-D7A8-410D-B40B-08031FFA19B8Q36066837-DD88A805-1912-441B-826B-43F620EF2490Q36318541-8CC9D0EA-BD42-4B0E-97A7-93091551CAC1Q36456638-7371B745-72EB-40CA-B9EC-D98B433E66B0Q37030008-AA8B2A2B-38E4-458C-94F5-FE037280EF93Q37428231-C970DA44-453B-4886-98B4-12E9CAF51543Q37682589-3D3428C1-3391-4EB6-9D6E-0FC10B17F7ECQ37763937-DE2A104B-4E3F-49E7-86CA-F6DD4D36FCA7Q37818317-951EC14E-A663-4B37-9E9D-C719B905C35AQ38018848-D64AC98E-58C4-4EB0-9E1A-C82A5E659DA0Q38148583-BDB67280-104D-4F5C-8796-2C1891565ED7Q39388922-E408EA96-D4FB-4D1D-AFE4-7812BE9F7144Q39762235-D2519FFA-05AE-4731-93C3-868BA7716903Q39947634-25EE438F-5DA9-4D5B-8F27-F96A14CB754AQ39985766-68108FD9-F2D2-4A03-8CF6-9FE8DAFCAD7CQ44682606-4D0A6C17-1275-4FD2-B94A-58C903AD527CQ44704166-D24E59D7-8372-4A31-BD39-5827EED2F56EQ47253303-AA37C5FD-B433-42CB-9BC3-C2E337CAEDC2Q47716837-4253DED4-AA37-4091-A356-9718015F4157
P2860
Proteomics in translational cancer research: toward an integrated approach.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Proteomics in translational cancer research: toward an integrated approach.
@ast
Proteomics in translational cancer research: toward an integrated approach.
@en
type
label
Proteomics in translational cancer research: toward an integrated approach.
@ast
Proteomics in translational cancer research: toward an integrated approach.
@en
prefLabel
Proteomics in translational cancer research: toward an integrated approach.
@ast
Proteomics in translational cancer research: toward an integrated approach.
@en
P1433
P1476
Proteomics in translational cancer research: toward an integrated approach.
@en
P2093
Julio E Celis
Pavel Gromov
P356
10.1016/S1535-6108(02)00242-8
P577
2003-01-01T00:00:00Z